Search results for "Hepatitis C virus"
Spotlight on hepatitis A, B, and C
The past month's gastroenterology research may not have been simple as ABC, but it did focus on the major types of hepatitis, including a hepatitis A outbreak, a comparison of hepatitis B drugs, and new data on hepatitis C complications and incidence.
https://gastroenterology.acponline.org/archives/2019/10/25/5.htm
25 Oct 2019
Spotlight on HCV guidance
Recommendations from the U.S. Preventive Services Task Force, the Kidney Disease: Improving Global Outcomes (KDIGO) work group, and the Choosing Wisely campaign all focused on hepatitis C virus (HCV) infection.
https://gastroenterology.acponline.org/archives/2019/09/27/5.htm
27 Sep 2019
Patients had high adherence to HCV treatment delivered in opioid agonist therapy programs
The hepatitis C virus (HCV) treatment completion rate was 97% among all participants, including those actively using drugs.
https://gastroenterology.acponline.org/archives/2019/04/26/6.htm
26 Apr 2019
MKSAP quiz: HCV-related cirrhosis with decompensation
This month's quiz asks readers to determine the next step in management for a 64-year-old man with hepatitis C virus (HCV)-related decompensation.
https://gastroenterology.acponline.org/archives/2019/03/22/4.htm
22 Mar 2019
Spotlight on direct-acting antivirals
Studies of contemporary populations with hepatitis C virus infection demonstrated that treatment with direct-acting antiviral therapies was linked to improvement in several long-term clinical outcomes.
https://gastroenterology.acponline.org/archives/2019/02/22/5.htm
22 Feb 2019
Reformulation of extended-release oxycodone may have triggered increase in hepatitis C rates
Hepatitis C virus infections increased three times faster in states with above-median rates of initial misuse of extended-release oxycodone (OxyContin) than in states with below-median rates, and the increase began immediately after a reformulation of the drug in 2010.
https://gastroenterology.acponline.org/archives/2019/02/22/1.htm
22 Feb 2019
Alcohol-related liver disease more likely to be diagnosed at advanced stages, study finds
On the other hand, viral hepatitis-related disease and nonalcoholic fatty liver disease are more likely to be treated early, due in part to the development of effective drugs for the former and increased awareness of the latter.
https://gastroenterology.acponline.org/archives/2019/02/22/3.htm
22 Feb 2019
More liver transplants occurring in patients with alcohol-associated liver disease
The increase from 2002 to 2016 can partly be explained by reductions in hepatitis C-related transplants but may also indicate changing perspectives on abstinence requirements, study authors said.
https://gastroenterology.acponline.org/archives/2019/01/25/4.htm
25 Jan 2019
Transplant of HCV-infected kidneys to HCV-negative recipients yields good outcomes at 12 months
The study authors concluded that their results should encourage efforts to increase use of hepatitis C virus (HCV)-infected kidneys and called for larger confirmatory trials.
https://gastroenterology.acponline.org/archives/2018/08/24/7.htm
24 Aug 2018
HCV-infected kidney transplants appear cost-effective in recipients with HCV
Transplanting a hepatitis C virus (HCV)-infected kidney and then administering HCV treatment was more effective and cost less than transplanting an HCV-uninfected kidney after HCV treatment in HCV-infected patients, mainly because the waiting list for uninfected kidneys is longer.
https://gastroenterology.acponline.org/archives/2018/07/27/6.htm
27 Jul 2018